STOCK TITAN

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
AngioDynamics, Inc. (NASDAQ: ANGO) announced that its President and CEO, Jim Clemmer, and EVP and CFO, Stephen Trowbridge, will present at the J.P. Morgan 42nd Annual Healthcare Conference on January 11, 2024. The presentation will focus on the company's medical technology innovations and cancer treatment advancements.
Positive
  • None.
Negative
  • None.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the J.P. Morgan 42nd Annual Healthcare Conference at 9:00 a.m. PT (12:00 p.m. ET) on Thursday, January 11, 2024 in San Francisco, CA.

A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

Investors:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

Source: AngioDynamics, Inc.

FAQ

What is the date of the J.P. Morgan 42nd Annual Healthcare Conference presentation by AngioDynamics, Inc. (NASDAQ: ANGO)?

The presentation is scheduled for January 11, 2024.

Who will be presenting at the J.P. Morgan 42nd Annual Healthcare Conference on behalf of AngioDynamics, Inc. (NASDAQ: ANGO)?

Jim Clemmer, President and CEO, and Stephen Trowbridge, EVP and CFO, will be presenting.

Where can I access the live webcast of the presentation by AngioDynamics, Inc. (NASDAQ: ANGO)?

The live webcast will be accessible through the 'Investors' section of the company's website at www.angiodynamics.com.

Will the webcast of the presentation be available for replay?

Yes, the webcast will be available for replay following the event.

AngioDynamics, Inc.

NASDAQ:ANGO

ANGO Rankings

ANGO Latest News

ANGO Stock Data

357.18M
38.36M
5.61%
81.33%
2.79%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
LATHAM